“TriSalus: SD-101 and SmartValve Technology” by Ehlert, Bird, Bergey, Bentivegna, Keehner, et al. …
Conference:
Track:
- 18
Title:
- TriSalus: SD-101 and SmartValve Technology
Director(s):
Description:
TriSalus’s investigational therapeutic candidate SD-101 has the potential to reprogram or eliminate immunosuppressive cells and enable immunotherapy in liver tumors.
